Skip to content
healthcare.dev

BLUDIGO

NDC 81284-315, indigotindisulfonate sodium, injection, from Provepharm Inc..

Product NDC
81284-315
Status
Listed
Labeler
Provepharm Inc.
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA216264
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/81284-315 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • INDIGOTINDISULFONATE SODIUM8 mg/mL

Pharmacologic classes

Diagnostic Dye [EPC]; Dyes [MoA]

Package NDCNDC-11Package
81284-315-05812840315055 AMPULE in 1 CARTON (81284-315-05) / 5 mL in 1 AMPULE (81284-315-00)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/73f246c4-b127-452e-856f-134b56cb8870

Use it

Look up 81284-315 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/81284-315 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 81284-315. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.